207 related articles for article (PubMed ID: 27698008)
1. Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients.
Meeder AM; van der Steen MS; Rozendaal A; van Zanten AR
BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27698008
[TBL] [Abstract][Full Text] [Related]
2. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients.
Newman PJ; Quinn AC; Grounds RM; Hunter JM; Boyd AH; Eastwood NB; Pollard BJ; Pearson AJ; Harper NJ; Beale RJ; Sutjarittam M; Elliot JM; Bion JF
Crit Care Med; 1997 Jul; 25(7):1139-42. PubMed ID: 9233738
[TBL] [Abstract][Full Text] [Related]
3. The infusion requirements and recovery characteristics of cisatracurium or atracurium in intensive care patients.
Pearson AJ; Harper NJ; Pollard BJ
Intensive Care Med; 1996 Jul; 22(7):694-8. PubMed ID: 8844237
[TBL] [Abstract][Full Text] [Related]
4. Cisatracurium dosing in a patient with hyperthermia.
Lim J; Cox J; Nguyen T; Arya R
Am J Health Syst Pharm; 2019 Jul; 76(14):1029-1032. PubMed ID: 31361873
[TBL] [Abstract][Full Text] [Related]
5. [The clinical pharmacology of cisatracurium].
Mellinghoff H; Diefenbach C
Anaesthesist; 1997 Jun; 46(6):481-5. PubMed ID: 9297378
[TBL] [Abstract][Full Text] [Related]
6. [Cisatracurium--is the stereoisomer an "ideal" relaxant? Histamine liberation and tryptase determination after bolus administration of cistracurium: a comparison with vecuronium].
Soukup J; Doenicke A; Hoernecke R; qass J
Anaesthesist; 1997 Jun; 46(6):486-91. PubMed ID: 9297379
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
Prielipp RC; Coursin DB; Scuderi PE; Bowton DL; Ford SR; Cardenas VJ; Vender J; Howard D; Casale EJ; Murray MJ
Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
[TBL] [Abstract][Full Text] [Related]
8. Cisatracurium and atracurium as antigens.
Fisher MM
Anaesth Intensive Care; 1999 Aug; 27(4):369-70. PubMed ID: 10470390
[TBL] [Abstract][Full Text] [Related]
9. Compared efficacy and tolerance of the neuromuscular blockade induced by brand-name (Nimbex®) and generic (Cisatrex®) of cisatracurium in mechanically ventilated critically ill patients: a crossover double-blind randomized study.
Fraj N; Meddeb K; Azouzi A; Romdhani S; Saad HB; Boussarsar M
Pan Afr Med J; 2020; 37():346. PubMed ID: 33738034
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Cisatracurium Versus Atracurium in Early ARDS.
Moore L; Kramer CJ; Delcoix-Lopes S; Modrykamien AM
Respir Care; 2017 Jul; 62(7):947-952. PubMed ID: 28351905
[TBL] [Abstract][Full Text] [Related]
11. The effect of cisatracurium infusion on the energy expenditure of critically ill patients: an observational cohort study.
Koekkoek WAC; Menger YA; van Zanten FJL; van Dijk D; van Zanten ARH
Crit Care; 2020 Feb; 24(1):32. PubMed ID: 32014039
[TBL] [Abstract][Full Text] [Related]
12. Infusion and bolus administration of cisatracurium--effects on histamine release.
Selcuk M; Celebioglu B; Celiker V; Basgul E; Aypar U
Middle East J Anaesthesiol; 2005 Jun; 18(2):407-19. PubMed ID: 16438016
[TBL] [Abstract][Full Text] [Related]
13. [Effects of priming technique on onset profile of cisatracurium].
Hoffmann W; Schwarz U; Ruoff M; Georgieff M; Geldner G
Anaesthesiol Reanim; 1999; 24(5):130-3. PubMed ID: 10596204
[TBL] [Abstract][Full Text] [Related]
14. [Effect of sevoflurane versus propofol-remifentanil anesthesia on neuromuscular blockade by continuous cisatracurium infusion].
Wen LL; Lin WQ; Zhao WX; Li GC; Bai XH; Xiao JB
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):163-5. PubMed ID: 20118012
[TBL] [Abstract][Full Text] [Related]
15. Cisatracurium or rocuronium versus rocuronium-cisatracurium combination.
Zeidan A; Nahle N; Maaliki H; Baraka A
Middle East J Anaesthesiol; 2006 Jun; 18(5):879-86. PubMed ID: 17094524
[TBL] [Abstract][Full Text] [Related]
16. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
Trissel LA; Martinez JF; Gilbert DL
Am J Health Syst Pharm; 1997 Aug; 54(15):1735-41. PubMed ID: 9262747
[TBL] [Abstract][Full Text] [Related]
17. Comparative study on the pharmacodynamics of cisatracurium: continuous infusion or intermittent bolus injection.
Dong YJ; Li X
Contemp Clin Trials; 2012 May; 33(3):482-5. PubMed ID: 22269820
[TBL] [Abstract][Full Text] [Related]
18. [The effect of different priming doses on the pharmacodynamics of cisatracurium].
Pühringer FK; Scheller A; Kleinsasser A; Löckinger A; Keller P; Raedler C; Keller C
Anaesthesist; 2000 Feb; 49(2):102-5. PubMed ID: 10756963
[TBL] [Abstract][Full Text] [Related]
19. Anaphylactoid reactions after cisatracurium administration in six patients.
Krombach J; Hunzelmann N; Köster F; Bischoff A; Hoffmann-Menzel H; Buzello W
Anesth Analg; 2001 Nov; 93(5):1257-9, table of contents. PubMed ID: 11682408
[TBL] [Abstract][Full Text] [Related]
20. Delayed recovery of limb muscle power after general anesthesia with cisatracurium in a dermatomyositis patient.
You AH; Kang HY; Park SW; Kim Y
J Clin Anesth; 2018 Nov; 50():59-60. PubMed ID: 29980001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
